Identification | Back Directory | [Name]
2,5-Diazaspiro[3.4]octane-5-carboxylic acid, 2-[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]-1-oxo-, 1,1-dimethylethyl ester, (4S)- | [CAS]
2151842-64-5 | [Synonyms]
GATE-251 AGN-241751 Zelquistinel 2,5-Diazaspiro[3.4]octane-5-carboxylic acid, 2-[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]-1-oxo-, 1,1-dimethylethyl ester, (4S)- | [Molecular Formula]
C15H25N3O5 | [MOL File]
2151842-64-5.mol | [Molecular Weight]
327.38 |
Chemical Properties | Back Directory | [Boiling point ]
564.0±50.0 °C(Predicted) | [density ]
1.30±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
13.97±0.20(Predicted) | [color ]
White to off-white |
Hazard Information | Back Directory | [Uses]
Zelquistinel (AGN-241751) is a N-methyl-D-aspartate (NMDA) receptor partial agonist used for the research of depression, anxiety and other related psychiatric disorders[1]. | [References]
[1] Khan, M. Amin, et al.Preparation of spiro-lactams as NMDA receptor modulators and uses thereof.WO2017201283A1 |
|
|